Biomarkers for Hepatocellular Apoptosis in the Management of Liver Diseases

Author(s): Marie V. St-Pierre, Jean-Francois Dufour

Journal Name: Current Pharmaceutical Biotechnology

Volume 13 , Issue 11 , 2012

Become EABM
Become Reviewer
Call for Editor


Apoptosis is a rare event in normal hepatocytes. However, multiple signals can trigger apoptosis in hepatocytes and it plays a role in the pathogenesis of many liver diseases. This review summarizes the mechanisms of hepatocellular apoptosis and the importance of apoptosis in the pathological processes of liver disease. The potential for non-invasive biomarkers of apoptosis to gauge the extent and follow the evolution of clinical disease is emphasized.

Keywords: Cytokeratin 18, Fas antigen, Fas ligand, Tumour necrosis factor, soluble trail, Biomarkers, Apoptosis, liver diseases, non-invasive biomarkers

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 13 August, 2012
Page: [2221 - 2227]
Pages: 7
DOI: 10.2174/138920112802502097
Price: $65

Article Metrics

PDF: 6